|
Paule de Blois
|
|
Vice-President,Operations, Diagnocure |
|
|
Johane Boucher-Champagne
|
|
Consultant, formerly CEO at Anapharm |
|
|
Fiona Costello
|
|
Associate Professor, Departments of Clinical Neurosciences and Surgery, Clinical Scientist, Hotchkiss Brain Institute |
|
|
Marilyn Emery
|
|
President and CEO, Women’s College Hospital |
|
|
Diane Finegood
|
|
President and CEO of the Michael Smith Foundation for Health Research |
|
|
Anne-Claude Gringras
|
|
Principal Investigator, Scientist, Mount Sinai Hospital |
|
|
Johane Guay
|
|
CEO, Biopharmacopae |
|
|
Mary Jo Haddad
|
|
President and CEO of SickKids Hospital |
|
|
Arlene King
|
|
Chief Medical Officer for Ontario |
|
|
Eugenia Kumacheva
|
|
Professor of Chemistry at the University of Toronto |
|
|
Barbara Leavitt
|
|
CEO of Baxter and Chair of the MEDEC Board |
|
|
Dalal Manoli
|
|
Consultant, formerly CEO at Biogentis, Phage Tech (now Targanta) & CuraMedica Canada |
|
|
Arlene Panting
|
|
CEO, Science Alberta Foundation |
|
|
Janice Parente
|
|
CEO, Ethical Clinical Research |
|
|
Louise Proulx
|
|
Vice-President, R&D, Vertex Canada (formerly Virochem) |
|
|
Molly Shoichet
|
|
President and Founder, Matregen, Professor of Chemical Engineering & Applied Chemistry, Chemistry and Biomaterials & Biomedical Engineering at the University of Toronto
|
|
|
Ilse Treurnicht
|
|
CEO of MaRS Discovery District |
|
